CSL Limited Reviews 2024 Performance at Annual Meeting 27d ago Company Announcements CSL Limited’s Strategic Issuance of Unquoted Securities 1M ago Company Announcements CSL Limited Hosts 2024 R&D Investor Briefing 1M ago The Fly Travere Therapeutics, CSL Vifor announce Swissmedic approval of FILSPARI...
CSL Behring AG, Berne, Switzerland, a wholly-owned subsidiary of global biotechnology leader CSL Limited (ASX: CSL; USOTC: CSLLY), today published the offer prospectus regarding its public tender offer for all publicly held registered shares of Vifor Pharma Ltd. (SIX:VIFN; ISIN:CH0364749348)...